NEISSERIA MENINGITIDIS SEROGROUP B NHBA FUSION PROTEIN ANTIGEN, NEISSERIA MENINGITIDIS SEROGROUP B FHBP FUSION PROTEIN ANTIGEN and NEISSERIA MENINGITIDIS SEROGROUP B NADA PROTEIN ANTIGEN
NEISSERIA MENINGITIDIS SEROGROUP B NHBA FUSION PROTEIN ANTIGEN, NEISSERIA MENINGITIDIS SEROGROUP B FHBP FUSION PROTEIN ANTIGEN and NEISSERIA MENINGITIDIS SEROGROUP B NADA PROTEIN ANTIGEN is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Bexsero. Available dosage form: injection, suspension.
Drug details
- Generic Name
- NEISSERIA MENINGITIDIS SEROGROUP B NHBA FUSION PROTEIN ANTIGEN, NEISSERIA MENINGITIDIS SEROGROUP B FHBP FUSION PROTEIN ANTIGEN and NEISSERIA MENINGITIDIS SEROGROUP B NADA PROTEIN ANTIGEN
- Brand Names
- Bexsero
- Application Number
- BLA125546
- Sponsor
- GlaxoSmithKline Biologicals SA
- NDC Codes
- 1
- Dosage Forms
- INJECTION, SUSPENSION
- Routes
- INTRAMUSCULAR
- Active Ingredients
- NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN ANTIGEN, NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN ANTIGEN, NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN ANTIGEN, NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 OUTER MEMBRANE VESICLE ANTIGEN